Staar Surgical (STAA) experienced a significant decline in operating profit in Q4 2024 compared to the same period in the previous year, while net sales increased. This discrepancy can be attributed to several factors:
- Increased Selling, General, and Administrative (SG&A) Expenses: The primary reason for the decrease in operating profit was the rise in SG&A expenses. This increase overshadowed the positive impact of higher gross profit, leading to a net decline in operating profit1.
- Provision for Income Taxes: Another factor contributing to the decrease in operating profit was the provision for income taxes. This indicates that the company faced higher tax liabilities, which negatively affected its profitability in the quarter.
In summary, despite a rise in revenue, the increased costs associated with SG&A and taxes led to a decline in operating profit for Staar Surgical in Q4 2024.